QTREX Registers 6.8M Warrant Shares for Armistice Capital Resale, Potential $4.75M Proceeds
QTEX has more than doubled off its 52-week low of $0.283.
Summary
QTREX registers 6.79 million shares for resale by Armistice Capital, stemming from a February 2026 private placement. The warrants have a $0.70 exercise price, potentially bringing in $4.75 million if exercised, but also creating resale overhang.
Key Events · Financing and Capital Events · QTEX
-
Registration of 6.79M Warrant Shares
An F-1 registration statement was filed for 6,785,715 ordinary shares underlying warrants held by Armistice Capital, a major institutional investor. These warrants stem from a private placement completed on February 5, 2026.
-
Potential $4.75M Cash Inflow
Exercising all warrants for cash at $0.70 per share would generate approximately $4.75 million in gross proceeds for QTREX, earmarked for working capital. As of the filing date, the company had only six months of cash runway.
-
Warrant Amendment Lowers Exercise Price
Existing December 2023 warrants held by Armistice to purchase 3,031,250 shares were amended: the exercise price dropped from $1.28 to $0.70, and the expiration was extended from June 2027 to February 2031, increasing potential dilution.
-
Resale Overhang Risk
Armistice Capital may sell the registered shares at any time, potentially pressuring the stock. The shares represent approximately 10.8% of outstanding shares (based on 55.7M shares outstanding).
Analysis · QTEX · Industrial Applications And Services
QTREX filed an F-1 to register 6.79 million shares underlying warrants held by Armistice Capital, a key institutional investor. The warrants were issued in a February 2026 private placement at an exercise price of $0.70 per share, well below the current $1.18 stock price. If all warrants are exercised for cash, the company would receive approximately $4.75 million—meaningful capital for a company with a going concern warning and only six months of cash runway. However, the registration enables Armistice to sell these shares into the market, creating potential overhang. The filing also reveals that existing December 2023 warrants held by Armistice were amended to reduce the exercise price from $1.28 to $0.70 and extend the expiration to 2031, aligning terms with the new warrants and increasing potential dilution.
How filings like this one have moved
In the 30 days to Sep 11, 2026, 30.2% of the 1943 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.21%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, QTEX was trading at $1.18 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $51.4M. The 52-week trading range was $0.28 to $3.85. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.